Mirae Asset Global ETFs Holdings
AVIR icon

Mirae Asset Global ETFs Holdings’s Atea Pharmaceuticals AVIR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$152K Sell
32,658
-1,093
-3% -$5.44K ﹤0.01% 2617
2026
Q1 		$182K Buy
33,751
+776
+2% +$3.56K ﹤0.01% 2411
2025
Q4 		$118K Sell
32,975
-2,998
-8% -$9.53K ﹤0.01% 2599
2025
Q3 		$104K Sell
35,973
-5,984
-14% -$20.4K ﹤0.01% 2632
2025
Q2 		$151K Sell
41,957
-4,135
-9% -$12.3K ﹤0.01% 2414
2025
Q1 		$138K Buy
46,092
+1,950
+4% +$6.09K ﹤0.01% 2489
2024
Q4 		$148K Buy
44,142
+1,900
+4% +$6.31K ﹤0.01% 2541
2024
Q3 		$142K Buy
42,242
+3,194
+8% +$11.6K ﹤0.01% 2540
2024
Q2 		$129K Buy
+39,048
New +$146K ﹤0.01% 2459

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's AVIR Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Atea Pharmaceuticals (AVIR) stake by 3.2% in Q2 2026, selling an estimated $5.44K and leaving 32,658 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #2617.

Mirae Asset Global ETFs Holdings first reported a position in AVIR in Q2 2024 and has held it in 9 quarters since. The position peaked at $182K in Q1 2026. 124 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 32,658 shares of Atea Pharmaceuticals worth $152K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 1,093 Atea Pharmaceuticals shares in Q2 2026, an estimated $5.44K.
  • Atea Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2617 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Atea Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Atea Pharmaceuticals position peaked at $182K in Q1 2026.
  • 124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.